Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Same here but I am adding. I join previous posters to say thank you to those longs who posted here during these long 3 years of awaiting the results with valuable research and insights. It was really helpful and motivating to hold on to the shares. I personally sold some along the way which in hindsight was a mistake (live and learn) but happy to add now when it's as de-risked as de-risked can be. As others stated will follow you guys to the next great thing :)
This might be a conspiracy theory but maybe he did so to report the change of under the 5% of share ownership. Now he can sell the rest without reporting / alarming the public. Price action will tell. Thoughts?
We're heading there or lower. I'll be a buyer then.
This unfortunately isn't true. As soon as the shares are registered (2-6 weeks) you can sell these shares Pursuant to Registration Statement on Form S-1.
Most importantly it seems you were right about having to conduct another trial for mono. I think the lesson here is try to listen to all views positive and negative to be a better investor.
Nader is aiming for 90%+ responders rate so definitely 700mg. That is what he has implied when he said things will be golden if they achieve this. He used the word "golden" again - I kid you not :)
It looks to me like Caracciolo wants out and they making it possible for him.
Are those recent form 4 fillings indicate that the board doesn't think sh price will reach a $1 before their warrant expiration date of 05/31/2022? That doesn't exactly inspire confidence.
No one would go for that.
I agree. It will likely go down to 0.45 again. This will only stop upon some proper financing announcement - hopefully soon.
You're wrong. "Common Stock issuable upon exercise of the Warrants" means that when you exercise your warrants @ 0.75 you will receive common stock (one share for one warrant). It has nothing to do with the subscribed shares that your are buying @ 0.50 in this private placement (as a "unit" together with half a warrant).
I found it. It was this:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=143357615
Complete and utter nonsense.
Is this with the latest raise? Does anybody has a link to this post?
"Although the unit holders can not get their shares til they exercise warrants"
Can you please explain this?
I have quoted number from the filling: "As a fee to the placement agent, the Company has agreed to pay a cash fee equal to 12% of the gross proceeds received from qualified investors in the offering".
Do you know something ? :)
One thing which is different with this raise is the commission is a lot higher (12%). How do we think market will react to the news?
You're wrong. Is says in the filling: "gross proceeds to the Company of approximately $8.4 million" so 8.4MM minus the commission to Paulson. It's not that difficult to understand - half a warrant is free for every purchase of one share. At this moment company does not get any money for these warrants - they're are giving them away as a reward for ponying up lump sum of money by each individual taking part in the placement.
I think that at the core of the problem is that the PRO 140 molecule has been known for over a decade and passed many hands so no one believes it will ever reach the market. Would feel good to prove everyone wrong though.
Let's pray that it comes true.
Snippet from Bloomberg about Argonne:
"The firm prefers to acquire majority stakes in its portfolio companies. It invests in operating companies with real estate holdings, broken or stalled-auctions, undermanaged or troubled assets, “End of fund” buyouts, and public-to-privates."
Full source: https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=4726744
Speculation. KZR looks over-extended here. Good short candidate?
The only other board I read other than here is the AUPH board which have had good discussions (still not as good as here) in the past but lately only the trolls seems to be posting as the company is in a bit of a limbo waiting for results. With regards to the share price surely CYDY looks cheap here - but is it the end of the decline? Probably not. When I look at my biotech watchlists and holdings only a couple have been rewarding for shareholders when looking at a 5 year chart. Is it best these days to sit on the sidelines and jump in at the last moment (big boys in and/or FDA approval?). Are you going to be rewarded for being in early or you going to get screwed for it. Just thinking out loud - not questioning anybody.
The reason I am here is that to my surprise there is a value here. Message boards are rarely a good place to study if you want to make money investing in the markets - quite the opposite. Even when Kss dropped coverage I have seen something in CYDY and continued to look for opinions of what other knowledgeable people think. I have been reading here probably close to 2 years now, been through the drama with pears and all that but never posted. I've been in and out from shares and got back in recently when Paulson appeared to be gone. Unfortunately this isn't the case as it seems. Another lesson learned. What I would like to do is to punch holes in our bull thesis just to have a better perspective as we seem to be completely ignored by the rest of the world and I would like to understand why.
Why would I be here if I wasn't invested? I probably own peanuts compare to some of you but it doesn't matter. I have what I am comfortable with at this moment in time. If we get financing at much more better terms I'll buy some more even if its not in the pennies anymore. Currently the sentiment in this sector seems rotten to me so I rather win less than lose more. My opinion only of course.
Do you have some examples from your other investments where good science has overcome bad management?
As I understand the question was somewhat different. I agree if the share price starts rising and reaches $3 / sh with continuing high volume it might as well go to $10, $20, etc which would be a validation of the value we all believe CYDY has. Taking $3 / share now was based on 'take it or leave it' offer with the current state of play of a lot of unknowns. I am starting to think the first price moving catalyst will be the mono which might be long way off and how much more dilution is going to occur until this happens. Hope I am wrong.
Good for you :)
When looking from the perspective of risk management I would at this moment in time. How many times have you held because "nothing can go wrong now" only to turn significant paper wins into loses? This is biotech.
misiu I can't comment on whether he knows or doesn't know what he is talking about. From my experience his track record is mixed but to be successful in biotech investing understanding and being able to evaluate the science is only one of the ingredients of a success. There is plenty of examples of mediocre science but wonderful stocks and at the same time companies with a breakthrough science gone bankrupt. I am beginning to think that biotech is closer to gambling than investing. Apologies but I gone off the topic. Time for bed.
I like your narrative. Statistically speaking the chances of this happening
are slim. I think it is in a human nature to convince ourselves that we have found the best thing since sliced bread and no one else knows about it.
I have managed to find the source of this comment (it's behind a paywall) https://www.stockgumshoe.com/2017/04/long-idea-of-the-year/comment-page-1/#comment-4931341
Thanks for your insight. I am mulling over taking part in a Paulson raise but still have the "if something looks to good to be true it usually is" at the back of my mind (meaning you get the "free" warrants by dumping shares but how good are these free warrants if CYDY keeps diluting and giving them away like candy). Also from my (rather short have to admit) experience in biotech "investing" averaging down has resulted in more losses most of the time.
I have first started to follow CYDY because of Dr KSS and his forum (initially on the Stock Gumshoe site) so he also knew about them. He had a favourable view but then dropped CYDY from coverage around March 2017 because, quote "virological breakthrough and resistance at about one year of therapy". I am not sure what was the source of that info.
That is a prudent move. If you had a chance to participate in the Paulson raise to get your first stake would you do it now or would you wait for the deal to close?
Just think of this: if the demand is so high why do they need to advertise the offering on a message board?
Another PR. That is a lot of resignations - doesn't look too promising to me. Will be interesting to see the sp action tomorrow.
The rationale behind the price decline could that less time is now left to dump the shares owned by Paulson's investors before a binary event (FDA meeting) so they are willing to get less for their shares and keep the warrants rather than be stuck with shares and warrants in case it goes horribly wrong. That is what I would do to reduce the risk in the current situation.
Don't get me wrong. I am long AUPH. I am far from an expert in this sector but logically speaking the only way BP would buy this is if its offered at a discount (to justify the risk of p3 failure). Why would Glickman sell this at a discount if he believes in a big success of Voclo? Surely it's better to wait for p3 results and then sell as they are fully funded until the trial is over.